NEW BRUNSWICK (dpa-AFX) - Genmab A/S (GMXAY.PK, GNMSF.OB) said that
worldwide net sales of Darzalex, or daratumumab, as reported by Johnson &
Johnson (JNJ) were $572 million in 2016. This comprised of net sales of $471
million in the U.S. and net...
PARIS (dpa-AFX) - Acorda Therapeutics Inc. (ACOR) has decided to discontinue
the development of Dalfampridine for treatment of post-stroke walking
difficulties, following disappointing results from its trial, dubbed MILESTONE.
Although the study...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.